An integrated quantification method to increase the precision, robustness, and resolution of protein measurement in human plasma samples

Clinical Proteomics

Volumn 12, Issue 1, 2015, Pages

  Li, Xiao Jun ^a   Lee, Lik Wee ^a   Hayward, Clive ^a   Brusniak, Mi Youn ^a,b   Fong, Pui Yee ^a   McLean, Matthew ^a,c   Mulligan, Joanne ^a   Spicer, Douglas ^a   Fang, Kenneth C ^a   Hunsucker, Stephen W ^a   Kearney, Paul ^a  

^a Integrated Diagnostics   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

Bioinformatics; Clinical proteomics; Immunoaffinity depletion; Mass spectrometry; Multiple reaction monitoring; Plasma or serum analysis; Quantitative proteomics

Indexed keywords

APOPTOSIS INDUCING FACTOR; CD14 ANTIGEN; COLLAGEN TYPE 1; FERRITIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GALECTIN 3; GAMMA GLUTAMYL HYDROLASE; GELSOLIN; GLUCOSE REGULATED PROTEIN; GLUCOSE REGULATED PROTEIN 94; LUMICAN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; PEROXIREDOXIN 1; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN EF1A1; PROTEIN GSLG1; PROTEIN TYROSINE KINASE; SCAVENGER RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3; STEM CELL FACTOR RECEPTOR; TENASCIN; TETRANECTIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG;

ACCURACY; AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; BIOINFORMATICS; BLOOD SAMPLING; CANCER PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; ISOTOPE LABELING; LUNG CANCER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONTE CARLO METHOD; MULTIPLE REACTION MONITORING; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; ROOM TEMPERATURE; SOLID PHASE EXTRACTION; VARIANCE;

EID: 84935922097     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-12-3     Document Type: Article

References (39)

1. Huttenhain R, Malmstrom J, Picotti P, Aebersold R: Perspectives of targeted mass spectrometry for protein biomarker verification. Curr Opin Chem Biol 2009, 13:518-25. 10.1016/j.cbpa.2009.09.014
2. Kuzyk MA, Smith D, Yang J, Cross TJ, Jackson AM, Hardie DB, et al.: Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009, 8:1860-77. 10.1074/mcp.M800540-MCP200
3. Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, et al.: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 2009, 27:633-41. 10.1038/nbt.1546
4. Kuhn E, Whiteaker JR, Mani DR, Jackson AM, Zhao L, Pope ME, et al.: Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Mol Cell Proteomics 2012,11(6):M111.013854. doi: 10.1074/mcp.M111.013854 10.1074/mcp.M111.013854
5. Anderson L, Hunter CL: Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006, 5:573-88.
6. Li XJ, Hayward C, Fong PY, Dominguez M, Hunsucker SW, Lee LW, et al.: A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med 2013, 5:207ra142.
7. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, et al.: A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol 2011, 29:625-34. 10.1038/nbt.1900
8. Huttenhain R, Soste M, Selevsek N, Rost H, Sethi A, Carapito C, et al.: Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med 2012, 4:142ra194.
9. Addona TA, Shi X, Keshishian H, Mani DR, Burgess M, Gillette MA, et al.: A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol 2011, 29:635-43. 10.1038/nbt.1899
10. Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-67. 10.1074/mcp.R200007-MCP200
11. Shi T, Su D, Liu T, Tang K, Camp DG 2nd, Qian WJ, et al.: Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics 2012, 12:1074-92. 10.1002/pmic.201100436
12. Barr JR, Maggio VL, Patterson DG Jr, Cooper GR, Henderson LO, Turner WE, et al.: Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin Chem 1996, 42:1676-82.
13. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP: Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003, 100:6940-5. 10.1073/pnas.0832254100
14. Picard G, Lebert D, Louwagie M, Adrait A, Huillet C, Vandenesch F, et al.: PSAQ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications. J Mass Spectrom 2012, 47:1353-63. 10.1002/jms.3106
15. Hanke S, Besir H, Oesterhelt D, Mann M: Absolute SILAC for accurate quantitation of proteins in complex mixtures down to the attomole level. J Proteome Res 2008, 7:1118-30. 10.1021/pr7007175
16. Singh S, Springer M, Steen J, Kirschner MW, Steen H: FLEXIQuant: a novel tool for the absolute quantification of proteins, and the simultaneous identification and quantification of potentially modified peptides. J Proteome Res 2009, 8:2201-10. 10.1021/pr800654s
17. Rivers J, Simpson DM, Robertson DH, Gaskell SJ, Beynon RJ: Absolute multiplexed quantitative analysis of protein expression during muscle development using QconCAT. Mol Cell Proteomics 2007, 6:1416-27. 10.1074/mcp.M600456-MCP200
18. Zeiler M, Straube WL, Lundberg E, Uhlen M, Mann M: A Protein Epitope Signature Tag (PrEST) library allows SILAC-based absolute quantification and multiplexed determination of protein copy numbers in cell lines. Mol Cell Proteomics 2012,11(3):O111.009613. doi: 10.1074/mcp.O111.009613 10.1074/mcp.O111.009613
19. Zhang H, Liu Q, Zimmerman LJ, Ham AJ, Slebos RJ, Rahman J, et al.: Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Mol Cell Proteomics 2011,10(6):M110.006593. doi:10.1074/mcp.M110.006593 10.1074/mcp.M110.006593
20. Ludwig C, Claassen M, Schmidt A, Aebersold R: Estimation of absolute protein quantities of unlabeled samples by selected reaction monitoring mass spectrometry. Mol Cell Proteomics 2012,11(3):M111.013987. doi: 10.1074/mcp.M111.013987 10.1074/mcp.M111.013987
21. Abbatiello SE, Mani DR, Schilling B, Maclean B, Zimmerman LJ, Feng X, et al.: Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS). Mol Cell Proteomics 2013, 12:2623-39. 10.1074/mcp.M112.027078
22. Griffin NM, Yu J, Long F, Oh P, Shore S, Li Y, et al.: Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol 2010, 28:83-9. 10.1038/nbt.1592
23. Vachani A, Pass HI, Rom WN, Midthun DE, Edell ES, Laviolette M, et al.: Validation of a multi-protein plasma classifier to identify benign lung nodules. J Thorac Oncol doi: 10.1097/JTO.0000000000000447
24. Chang CY, Sabido E, Aebersold R, Vitek O: Targeted protein quantification using sparse reference labeling. Nat Methods 2014, 11:301-4. 10.1038/nmeth.2806
25. Qian WJ, Kaleta DT, Petritis BO, Jiang H, Liu T, Zhang X, et al.: Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics 2008, 7:1963-73. 10.1074/mcp.M800008-MCP200
26. Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, Bletz JA, et al.: A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol Cell Proteomics 2011,10(9):M110.006353. doi: 10.1074/mcp.M110.006353 10.1074/mcp.M110.006353
27. Xu Q-S, Liang Y-Z: Monte Carlo cross validation. Chemometr Intell Lab Syst 2001, 56:1-11. 10.1016/S0169-7439(00)00122-2
28. Scherer A. Batch effects and noise in microarray experiments: sources and solutions. J. Wiley: Chichester, U.K; 2009.
29. Boedigheimer MJ, Wolfinger RD, Bass MB, Bushel PR, Chou JW, Cooper M, et al.: Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories. BMC Genomics 2008, 9:285. 10.1186/1471-2164-9-285
30. Chen C, Grennan K, Badner J, Zhang D, Gershon E, Jin L, et al.: Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS One 2011,6(2):e17238. doi: 10.1371/journal.pone.0017238 10.1371/journal.pone.0017238
31. Reimer J, Shamshurin D, Harder M, Yamchuk A, Spicer V, Krokhin OV: Effect of cyclization of N-terminal glutamine and carbamidomethyl-cysteine (residues) on the chromatographic behavior of peptides in reversed-phase chromatography. J Chromatogr A 2011, 1218:5101-7. 10.1016/j.chroma.2011.05.079
32. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al.: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817-26. 10.1056/NEJMoa041588
33. Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, et al.: Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006, 6:150-60. 10.1111/j.1600-6143.2005.01175.x
34. Lange V, Picotti P, Domon B, Aebersold R: Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008, 4:222.
35. Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, Domon B, et al.: High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010, 7:43-6. 10.1038/nmeth.1408
36. Janes H, Pepe MS: Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. Am J Epidemiol 2008, 168:89-97. 10.1093/aje/kwn099
37. Huang Y, Pepe MS: Biomarker evaluation and comparison using the controls as a reference population. Biostatistics 2009, 10:228-44. 10.1093/biostatistics/kxn029
38. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-45. 10.2307/2531595
39. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C: the art of scientific computing. 2nd ed. Cambridge; New York: Cambridge University Press; 1992.